Salem Radio Network News Monday, October 20, 2025

Health

Novo Nordisk says Wegovy pill shows comparable weight-loss to injectable version

Carbonatix Pre-Player Loader

Audio By Carbonatix

(Reuters) -Novo Nordisk’s experimental Wegovy pill showed a 16.6% weight-loss in a late-stage study, according to data published in The New England Journal of Medicine on Wednesday, which is comparable to previous trial results of injectable Wegovy.

(Reporting by Puyaan Singh in Bengaluru; Editing by Shinjini Ganguli)

Previous
Next
The Media Line News
Salem Media, our partners, and affiliates use cookies and similar technologies to enhance your browsing experience, analyze site traffic, personalize site content, and deliver relevant video recommendations. By using this website and continuing to navigate, you consent to our use of such technologies and the sharing of video viewing activity with third-party partners in accordance with the Video Privacy Protection Act and other privacy laws. Privacy Policy
OK
X CLOSE